Ignite Creation Date:
2024-05-05 @ 5:06 PM
Last Modification Date:
2024-10-26 @ 9:28 AM
Study NCT ID:
NCT00387894
Status:
TERMINATED
Last Update Posted:
2013-06-04
First Post:
2006-10-12
Brief Title:
Erlotinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Sponsor:
Michael Prados
Organization:
University of California San Francisco
Organization Data
Organization:
University of California San Francisco
Class:
OTHER
Study ID:
CDR0000492762
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Michael Prados
Lead Sponsor Class:
OTHER
Responsible Party:
Michael Prados
Responsible Party Title:
Professor
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
University of California San Francisco
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Genentech Inc | INDUSTRY |
| National Cancer Institute NCI | NIH |